**Core Concept**
The underlying principle being tested is the mechanism of action of β-blockers in the context of glaucoma management, specifically how they reduce intraocular pressure (IOP). β-blockers are used to treat glaucoma by decreasing the production of aqueous humor.

**Why the Correct Answer is Right**
Although the specific correct answer choice is not provided, β-blockers typically act by reducing the production of aqueous humor through their effect on the β-adrenergic receptors in the ciliary body of the eye. This reduction in aqueous humor production leads to a decrease in intraocular pressure, which is beneficial in the management of glaucoma.

**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific details of each option, it's challenging to provide a precise explanation for why each might be incorrect. However, generally, if an option suggested β-blockers act by increasing aqueous outflow or through a mechanism unrelated to β-adrenergic receptors in the eye, it would be incorrect.
**Option B:** Similarly, if this option proposed a different, unrelated mechanism of action, it would not accurately describe how β-blockers reduce IOP in glaucoma patients.
**Option C:** This option might be incorrect if it suggested β-blockers have no effect on aqueous humor production or if it proposed an incorrect mechanism of action.
**Option D:** Without knowing the specifics, if this option suggested an irrelevant or incorrect pathway for β-blocker action in glaucoma, it would be the wrong choice.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that β-blockers, such as timolol, are effective in reducing intraocular pressure by decreasing the production of aqueous humor, making them a common first-line treatment for glaucoma.

**Correct Answer:** Correct Answer: D. Decreasing the production of aqueous humor.